To improve the care and outcomes of kidney disease patients worldwide through promoting coordination, collaboration and integration of initiatives to develop and implement clinical practice guidelines.
Home
Guidelines for Transplantation
Guideline Organization
Sub-topic
CARI-Australia
CMV Disease and Kidney Transplantation (2004)
CMV Disease and Kidney Transplantation
Deceased Kidney Donor Suitability (2005)
Deceased Kidney Donor Suitability
Calcineurin Inhibitors in Renal Transplantation (2007)
Calcineurin Inhibitors in Renal Transplantation
Living Kidney Donors (2007)
Draft - Under development
Living Kidney Donors
CSN-Canada
EBPG-Europe
European Best Practice Guidelines for Renal Transplantation
Part 1: 2000 Sections I-III
Part 2: 2002 Section IV
EVALUATION AND SELECTION OF DONORS
THE TRANSPLANT RECIPIENT FROM INITIAL TRANSPLANT HOSPITALIZATION TO 1 YEAR POST-TRANSPLANT
LONG-TERM MANAGEMENT OF THE TRANSPLANT RECIPIENT
KDOQI-US
Anemia in Chronic Kidney Disease (2006)
Bone Metabolism and Disease in Chronic Kidney Disease 2003
Bone Metabolism and Disease in Chronic Kidney Disease in Children 2005
Hypertension and Antihypertensive Agents in Chronic Kidney Disease 2006
UK-Renal Association
Module 4: Transplantation2007
Module 2: Complications 2007
Transplantation
Cardiovascular Disease: 1.9 Hypertension in renal transplant patients
National Institute for Health and Clinical Excellence (NICE) – United Kingdom